Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 110.9 | 100.8 | 103.3 | 85.0 | 64.5 |
| Revenue growth | 10.0% | -2.4% | 21.5% | 31.7% | |
| Cost of goods sold | 23.1 | 20.2 | 19.9 | 13.4 | 9.5 |
| Gross profit | 87.8 | 80.6 | 83.4 | 71.5 | 55.1 |
| Gross margin | 79.2% | 79.9% | 80.8% | 84.2% | 85.3% |
| Sales and marketing | 60.4 | 59.5 | 64.0 | 46.1 | 35.0 |
| Research and development | 39.6 | 35.0 | 31.6 | 21.4 | 17.7 |
| General and administrative | 24.2 | 20.1 | 14.9 | 6.0 | 4.6 |
| EBIT | -36.3 | -33.9 | -27.0 | -1.9 | -2.3 |
| EBIT margin | -32.7% | -33.6% | -26.2% | -2.3% | -3.5% |
| Pre-tax income | -37.4 | -33.8 | -27.1 | -3.0 | -2.0 |
| Income taxes | -0.5 | 1.6 | 1.0 | 1.3 | 0.8 |
| Tax rate | 1.4% | | | | |
| Net income | -36.9 | -35.4 | -28.1 | -4.3 | -2.8 |
| Net margin | -33.3% | -35.1% | -27.2% | -5.0% | -4.3% |
| |
| Diluted EPS | ($0.99) | ($0.99) | ($1.04) | ($0.53) | ($0.35) |
| Shares outstanding (diluted) | 37.2 | 35.7 | 27.1 | 8.0 | 7.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|